37.96 USD
▲-1.43+12.99%
2026-08-03
市值
$106.27M
市盈率
—
EPS
—
股息率
—
52 周区间
14.03 – 46.95
成交量
39.74K
Beta
2.08
目标价
58.00
52W 低 14.0352W 高 46.95
价格走势
公司简介
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company’s candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves’ disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.